SCOPUS 정보 검색 플랫폼

Expert Opinion on Investigational Drugs

Volumn 18, Issue 6, 2009, Pages 869-871

Mepolizumab for difficult-to-control asthma with persistent sputum eosinophilia

(1) Antoniu, Sabina A a

a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY (Romania)

Author keywords

Asthma; Eosinophilic airways inflammation; IL 5; Mepolizumab

Indexed keywords

CORTICOSTEROID; MEPOLIZUMAB; PREDNISONE;

ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EOSINOPHILIA; HUMAN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPUTUM;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; DRUG THERAPY, COMBINATION; EOSINOPHILIA; HUMANS; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPUTUM;

EID: 67649622321 PISSN: 13543784 EISSN: None Source Type: Journal
DOI: 10.1517/13543780902922678 Document Type: Review

Times cited : (9)

References (12)

1
- 0025037094
- Eosinophilic inflammation in asthma
- Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039 (Pubitemid 20336962)
- (1990) New England Journal of Medicine , vol.323 , Issue.15 , pp. 1033-1039
- Bousquet, J.¹ Chanez, P.² Lacoste, J.Y.³ Barneon, G.⁴ Ghavanian, N.⁵ Enander, I.⁶ Venge, P.⁷ Ahlstedt, S.⁸ Simony-Lafontaine, J.⁹ Godard, P.¹⁰ Michel, F.-B.¹¹

2
- 0036900913
- Eosinophilic inflammation in sputum of poorly controlled asthmatics
- Romagnoli M, Vachier I, Tarodo de la Fuente P, et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002;20:1370-1377
- (2002) Eur Respir J , vol.20 , pp. 1370-1377
- Romagnoli, M.¹ Vachier, I.² Tarodo De La Fuente, P.³

3
- 15144358845
- Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
- Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998;157:204-209 (Pubitemid 28071284)
- (1998) American Journal of Respiratory and Critical Care Medicine , vol.157 , Issue.1 , pp. 204-209
- Shi, H.-Z.¹ Xiao, C.-Q.² Zhong, D.³ Qin, S.-M.⁴ Liu, Y.⁵ Liang, G.-R.⁶ Xu, H.⁷ Chen, Y.-Q.⁸ Long, X.-M.⁹ Xie, Z.-F.¹⁰

4
- 0035744652
- Cytokines in asthma
- Kips JC. Cytokines in asthma. Eur Respir J 2001;34(Suppl.):24s-33s (Pubitemid 34760606)
- (2001) European Respiratory Journal, Supplement , vol.18 , Issue.34
- Kips, J.C.¹

5
- 33751023463
- Imatinib mesylate for the treatment of hypereosinophilic syndromes
- Antoniu SA. Imatinib mesylate for the treatment of hypereosinophilic syndromes. Curr Opin Investig Drugs 2006;7:980-984 (Pubitemid 44756123)
- (2006) Current Opinion in Investigational Drugs , vol.7 , Issue.11 , pp. 980-984
- Antoniu, S.A.¹

6
- 36749065556
- A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
- DOI 10.1164/rccm.200701-085OC
- Flood-page P, Swenson C, Faiferman I, et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 2007;176:1062-1071 (Pubitemid 350223751)
- (2007) American Journal of Respiratory and Critical Care Medicine , vol.176 , Issue.11 , pp. 1062-1071
- Flood-Page, P.¹ Swenson, C.² Faiferman, I.³ Matthews, J.⁴ Williams, M.⁵ Brannick, L.⁶ Robinson, D.⁷ Wenzel, S.⁸ Busse, W.⁹ Hansel, T.T.¹⁰ Barnes, N.C.¹¹

7
- 61849086181
- Mepolizumab and exacerbations of refractory eosinophilic asthma
- Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-984
- (2009) N Engl J Med , vol.360 , pp. 973-984
- Haldar, P.¹ Brightling, C.E.² Hargadon, B.³

8
- 61849155730
- Mepolizumab for prednisone-dependent asthma with sputum eosinophilia
- Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-993
- (2009) N Engl J Med , vol.360 , pp. 985-993
- Nair, P.¹ Pizzichini, M.M.² Kjarsgaard, M.³

9
- 0034526865
- Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions
- American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-2351 (Pubitemid 32051710)
- (2000) American Journal of Respiratory and Critical Care Medicine , vol.162 , Issue.6 , pp. 2341-2351
- Wenzel, S.E.¹ Fahy, J.V.² Irvin, C.³ Peters, S.P.⁴ Spector, S.⁵ Szefler, S.J.⁶ Casale, T.B.⁷ Cloutier, M.M.⁸ Elias, J.A.⁹ Liu, M.C.¹⁰ Taggert, V.¹¹

10
- 6644229440
- Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
- Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148
- (2000) Lancet , vol.356 , pp. 2144-2148
- Leckie, M.J.¹ Ten Brinke, A.² Khan, J.³

11
- 0037718532
- Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
- Buttner C, Lun A, Splettstoesser T, et al. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003;21:799-803
- (2003) Eur Respir J , vol.21 , pp. 799-803
- Buttner, C.¹ Lun, A.² Splettstoesser, T.³

12
- 40949146020
- Treatment of patients with the hypereosinophilic syndrome with mepolizumab
- Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008;358:1215-1228
- (2008) N Engl J Med , vol.358 , pp. 1215-1228
- Rothenberg, M.E.¹ Klion, A.D.² Roufosse, F.E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.